|
|
(1) Intestinal Organoid Models for APC LOH
|
5R21CA208638-02
|
$192,406
|
$192,406
|
GIARDINA, CHARLES
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
|
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients
|
5R21CA205636-02
|
$202,275
|
$202,275
|
CHEN, GRACE
|
UNIVERSITY OF MICHIGAN
|
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-08
|
$704,474
|
$119,761
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
(PQ #10) Gut-brain interactions underlying chemotherapy-induced behavioral comorbidities
|
1R01CA216290-01
|
$338,903
|
$338,903
|
PYTER, LEAH
|
OHIO STATE UNIVERSITY
|
|
|
(PQ1) Cellular senescence as an initiating event in malignant transformation
|
1R21CA206013-01A1
|
$203,400
|
$203,400
|
DAVID, GREGORY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
|
5R01CA205258-02
|
$464,261
|
$464,261
|
GUDAS, LORRAINE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
|
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
|
5R01CA206026-02
|
$356,850
|
$356,850
|
WALDMAN, SCOTT
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
(PQ10) Do microbiota alter the epigenetic landscape in human genome
|
5R21CA208464-02
|
$212,063
|
$212,063
|
STRONGIN, ALEX
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
|
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
|
5R01CA208644-02
|
$377,438
|
$377,438
|
CRITTENDEN, MARKA
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
|
(PQ3) Immune Modulation of DNA Mismatch Repair in Colorectal Cancer
|
5R01CA206010-02
|
$369,639
|
$369,639
|
CARETHERS, JOHN
|
UNIVERSITY OF MICHIGAN
|
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-02
|
$518,165
|
$518,165
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
|
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas
|
5R21CA208463-02
|
$174,000
|
$174,000
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer
|
5R01CA206465-02
|
$527,068
|
$527,068
|
JUSTICE, AMY
|
YALE UNIVERSITY
|
|
|
(PQ5) Investigation of intertumoral and intratumoral heterogeneity of mitochondrial apoptotic sensitivity
|
5R01CA205967-02
|
$386,588
|
$386,588
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INST
|
|
|
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
|
1R01CA220004-01
|
$739,041
|
$739,041
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-02
|
$529,795
|
$529,795
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
|
1R01CA208735-01A1
|
$729,393
|
$729,393
|
FELSHER, DEAN
|
STANFORD UNIVERSITY
|
|
|
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
|
5R01CA190092-04
|
$552,684
|
$552,684
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
5R01CA184820-04
|
$386,650
|
$386,650
|
DUBOIS, RAYMOND
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
|
5R01CA184926-04
|
$765,544
|
$765,544
|
JAFFEE, ELIZABETH
|
JOHNS HOPKINS UNIVERSITY
|
|
|
(PQB-4) Opposing Effects of the SASP in Cancer Progression
|
5R01CA184572-04
|
$329,925
|
$108,875
|
HERBIG, UTZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
|
(PQB-4) Single cell analysis strategy for monitoring drug responses of tumors
|
5R01CA190122-04
|
$571,080
|
$571,080
|
TIAN, QIANG
|
INSTITUTE FOR SYSTEMS BIOLOGY
|
|
|
(PQC-1) Driver Events In IBD-Associated Neoplastic Progression
|
5R01CA190040-04
|
$613,138
|
$613,138
|
MELTZER, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
(PQC1) Accelerated biological aging and colon polyp to cancer progression
|
5R01CA194663-03
|
$401,482
|
$401,482
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
(PQC2) Optical Hallmarks of Aggressive Clones Within Oral Field Cancerization
|
5R01CA185207-04
|
$640,637
|
$640,637
|
RICHARDS-KORTUM, REBECCA
|
RICE UNIVERSITY
|
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
5R01CA185357-04
|
$398,393
|
$398,393
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$238,588
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-08
|
$1,258,708
|
$566,419
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192973-04
|
$191,836
|
$95,918
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156734-07
|
$1,700,705
|
$102,042
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-03S1
|
$63,140
|
$63,140
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
5P20CA192994-03
|
$288,919
|
$288,919
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
|
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi
|
5U01CA181770-04
|
$507,599
|
$507,599
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
15-LOX-1 Modulation of Colon Cancer Promotion by Linoleic Acid
|
5R01CA206539-02
|
$366,000
|
$366,000
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
|
5R01CA195686-02
|
$366,000
|
$366,000
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
15-PGDH in Cholangiocarcinogenesis
|
5R01CA102325-11
|
$344,269
|
$344,269
|
WU, TONG
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-08
|
$919,471
|
$36,779
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
|
5P20CA192996-03
|
$154,908
|
$154,908
|
MCCOMBIE, WILLIAM
|
COLD SPRING HARBOR LABORATORY
|
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-08
|
$1,192,222
|
$858,400
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-04
|
$144,556
|
$76,615
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
|
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156732-07
|
$1,834,682
|
$256,855
|
VISWANATH, KASISOMAYAJULA
|
DANA-FARBER CANCER INST
|
|
|
2/2, University of Guam/University of Hawaii Cancer Center Partnership
|
5U54CA143728-08
|
$943,190
|
$405,572
|
UNDERWOOD, ROBERT
|
UNIVERSITY OF GUAM
|
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-12
|
$407,680
|
$114,150
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
|
2017 Cholangiocarcinoma Foundation Annual Conference
|
1R13CA213778-01
|
$5,000
|
$5,000
|
LINDSEY, STACIE
|
CHOLANGIOCARCINOMA FOUNDATION
|
|
|
2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization
|
5R01CA194307-02
|
$548,690
|
$548,690
|
EISENBREY, JOHN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-12
|
$1,170,535
|
$105,348
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
3D Dynamic Contrast-Enhanced US for Monitoring Chemotherapy of Liver Metastasis
|
5R01CA195443-02
|
$252,908
|
$252,908
|
WILLMANN, JUERGEN
|
STANFORD UNIVERSITY
|
|
|
A cell-based liquid biopsy approach for early pancreatic cancer detection
|
5F32CA196120-03
|
$57,066
|
$57,066
|
BHAGWAT, NEHA
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
A Clinical Validation Center for Early Detection of Pancreatic Cancer
|
5U01CA200468-02
|
$1,759,344
|
$1,759,344
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
A differentiation-based mechanism limiting pancreatic tumor initiation
|
5F30CA192819-03
|
$40,653
|
$40,653
|
KRAH, NATHAN
|
UNIVERSITY OF UTAH
|
|
Total relevant funding to Digestive Diseases for this search: $532,523,882
|
